Business Context and Reporting Period
Company: Disc Medicine, Inc. (Nasdaq: IRON)
Filing Type: Form 8-K (Current Report)
Date of Report: November 12, 2024
Reporting Period: Quarter ended September 30, 2024
Event: Announcement of financial results and corporate update.
Key Financial Metrics
The provided filing text serves as a cover document referencing a press release (Exhibit 99.1) for detailed data. Consequently, the filing text does not provide clear values for the following metrics:
- Revenue
- Net Profit/Loss
- Cash Flow
- Profit Margins
- Debt Levels
- Liquidity Position
Material Changes
The filing text does not contain specific numerical comparisons or descriptions of material changes versus the prior comparable period. Investors must refer to the attached press release (Exhibit 99.1) for this information.
Guidance, Outlook, and Risks
Management Commentary: The company announced a corporate update alongside financial results, though specific details of the update are not included in this text.
Legal Status: The information furnished in Item 2.02 and Exhibit 99.1 is not deemed "filed" under Section 18 of the Exchange Act and is not incorporated by reference into other filings unless expressly stated.
Risks/Contingencies: No specific risks or contingencies are detailed in the provided text.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for actual revenue, net loss, and cash burn figures for Q3 2024.
- Verify the specific details of the "corporate update" mentioned in the announcement.
- Confirm current cash runway and liquidity status as these are not stated in the 8-K text.
- Check for any new guidance or clinical trial milestones provided in the full press release.